Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroid hormone analogs and fetal goiter

F Comite, G N Burrow, E C Jorgensen

    Endocrinology
    |June 1, 1978
    PubMed
    Summary

    Thyroid hormone analogs, unlike thyroxine (T4) and triiodothyronine (T3), effectively prevent fetal goiter without causing maternal hyperthyroidism. These nonhalogenated analogs show promise for improved placental transfer and fetal thyroid hormone regulation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Screening of frailty in elderly patients with disability by the means of Marigliano-Cacciafesta polypathology scale (MCPS) and Canadian Study of Health and Aging (CSHA) scales.

    Archives of gerontology and geriatrics·2012
    Same author

    Editorial: behavior problems and precocious puberty: a role for clonidine?

    Journal of child and adolescent psychopharmacology·2009
    Same author

    Use of multiple providers for regular care and women's receipt of hormone replacement therapy counseling.

    Medical care·2001
    Same author

    The evolution of women as physicians and surgeons.

    The Annals of thoracic surgery·2001
    Same author

    Are women being counseled about estrogen replacement therapy?

    Medical care research and review : MCRR·2000
    Same author

    The liberal arts physician.

    Academic medicine : journal of the Association of American Medical Colleges·1999

    Area of Science:

    • Endocrinology
    • Reproductive Biology
    • Pharmacology

    Background:

    • Placental transfer of iodothyronines like thyroxine (T4) and triiodothyronine (T3) is generally limited in most mammalian species.
    • Developing methods to enhance thyroid hormone availability to the fetus is crucial for preventing developmental issues.
    • Recent synthesis of nonhalogenated thyroid hormone analogs offers potential for improved placental transport.

    Purpose of the Study:

    • To evaluate the efficacy of novel, nonhalogenated thyroid hormone analogs in crossing the placenta.
    • To compare the placental transfer efficiency of these analogs against traditional thyroid hormones (T4 and T3).
    • To assess the potential of these analogs to prevent fetal goiter without inducing maternal toxicity.

    Main Methods:

    • A rat model was used to compare the doses of T4, T3, and synthesized thyroid hormone analogs.
    • Propylthiouracil was administered to induce goiter in rat fetuses.
    • The doses required for each compound to prevent fetal goiter were determined and maternal effects were monitored.

    Main Results:

    • Both T4 and T3 successfully prevented fetal goiter but necessitated doses that resulted in maternal hyperthyroidism.
    • The novel thyroid hormone analogs also prevented fetal goiter effectively.
    • Crucially, the analogs prevented fetal goiter at doses that did not cause maternal hyperthyroidism, indicating better maternal safety and potentially enhanced transfer.

    Conclusions:

    • Nonhalogenated thyroid hormone analogs demonstrate superior placental transfer capabilities compared to T4 and T3.
    • These analogs offer a promising therapeutic strategy for managing fetal thyroid hormone deficiency without adverse maternal effects.
    • Further research into these analogs could lead to improved treatments for conditions affecting fetal thyroid health.

    Related Experiment Videos